Cite Filings / NRXP
Feed Companies Filings Check
Sign in

CIK 0001719406 · Non-accelerated filer<br>Smaller reporting company

NRX Pharmaceuticals, Inc.

Sign in to watch
Ticker
NRXP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
822844431
Phone
484-254-6134
Business address
1201 ORANGE STREET, SUITE 600, WILMINGTON, DE, 19801
Former names
Big Rock Partners Acquisition Corp.
Filings Financials Insiders Search text
All 479 Financials 180 Shareholder Meetings 25 Executive Compensation 166 Insider Trading 84 Beneficial Ownership Interest 46 Business Combinations 153 Public Offerings 101 Mutual Funds and ETFs 14 Others 41
›
Filed in
  1. No filings match these filters. Clear filters
  2. DEF 14A Proxy Proxy Statement 2026-11-05
  3. DEF 14A Proxy Proxy Statement 2026-02-23
  4. DEF 14A Proxy Proxy Statement 2024-09-05
  5. DEF 14A Proxy Proxy Statement 2024-03-11
  6. DEF 14A Proxy Proxy Statement 2023-11-22
  7. DEF 14A Proxy Proxy Statement 2023-01-10
  8. DEF 14A Proxy Proxy Statement 2022-06-21
  9. DEF 14A Proxy Proxy Statement 2021-04-01
  10. DEF 14A Proxy Proxy Statement 2020-12-07
  11. DEF 14A Proxy Proxy Statement 2020-07-10
  12. DEF 14A Proxy Proxy Statement 2020-03-09
  13. DEF 14A Proxy Proxy Statement 2019-11-08
  14. DEF 14A Proxy Proxy Statement 2019-08-09
  15. DEF 14A Proxy Proxy Statement 2019-05-07

Page 1 of 1 · 14 filings

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…